Tesser on vagus nerve stimulation as a non-drug approach to rheumatoid arthritis
What if your rheumatoid arthritis could be treated through your nerves, not your immune system?
Episode aired Feb 25, 2025·Page synthesised Jun 8, 2026·Last reviewed Jun 8, 2026
What this episode covers
- An implantable device the size of a penny may treat rheumatoid arthritis (RA) by stimulating the vagus nerve for one minute per day, instead of with immunosuppressive drugs.
- Clinical trials in patients who failed standard therapies show meaningful reductions in disease activity.
- The approach may be especially useful for people who cannot tolerate drugs or who struggle with complex injection regimens.
Why it matters
If neural stimulation can meaningfully reduce inflammation in rheumatoid arthritis, then similar approaches may apply to Crohn's disease, multiple sclerosis, and other autoimmune conditions where standard treatments suppress the whole immune system. The shift may also affect how often patients face the side effects, infection risks, and costs of long-term immunosuppression.
What stands out
- One minute of daily vagus nerve stimulation may reduce rheumatoid arthritis disease activity, despite the simplicity of the intervention compared to multi-drug regimens (controlled clinical trial data)
- The approach works by activating the body's natural anti-inflammatory reflex rather than by suppressing the immune system (mechanistic + animal studies + early clinical data)
- A penny-sized implantable device delivers the entire intervention, with no daily injections or pills needed (device description + trial protocols)
Best-supported action
The single highest-leverage move from this episode, anchored in the strongest evidence the speaker presents.
If you have rheumatoid arthritis that has not responded to multiple drug therapies, consider asking your rheumatologist whether vagus nerve stimulation trials may apply to your case.
Other supported actions
Further actions discussed in this episode, ordered from strongest to weakest evidence. This is one expert's view, the full topic compares and ranks across experts.
- Consider asking your rheumatologist whether you are eligible for a vagus nerve stimulation trial, especially after multiple biologics have failed to control your rheumatoid arthritis.Strong evidence
- Consider keeping a symptom journal (joint pain, stiffness, fatigue on 1-10 scales) for 4-6 weeks before any new RA treatment, to give your clinician a clear baseline to track response against.Moderate evidence
- Discuss the side-effect profile of your current rheumatoid arthritis drugs with your rheumatologist if you are considering a bioelectronic device; what your current treatment costs in side effects matters for the comparison.Moderate evidence
Full context, impact ratings, and timing — available in related topics
Questions to take to your doctor
- Given my rheumatoid arthritis history and how I have responded to past treatments, am I eligible for any active vagus nerve stimulation trials?
- Given the surgical risks of implantation, how would you weigh those against my current drug side effects and long-term outlook?
- Given that the device is still in late-stage trials, what would my treatment look like if results don't hold up at longer follow-up?
Full doctor prep with ranked questions available in the full topic page
Context
Clinician-investigator focused on rheumatoid arthritis and the SetPoint Medical vagus nerve stimulation device trials. Tends to view bioelectronic medicine as a credible third category of intervention alongside drugs and surgery, while acknowledging the surgical and long-term-data uncertainties that remain.
This does not prove that vagus nerve stimulation works for all rheumatoid arthritis patients; trials have focused on patients who failed prior therapies.
This does not prove that vagus nerve stimulation is safer than established drugs in the long term; longer follow-up is still needed.
This does not prove that bioelectronic devices will replace biologic and disease-modifying drugs; both may be used together.
This does not mean you should change or stop any current medical treatment on your own.
Where people go wrong
- Discontinuing established rheumatoid arthritis drugs in hopes that vagus nerve stimulation will replace them.May cause an RA flare. Vagus nerve stimulation is not yet a proven replacement for established biologic and disease-modifying therapy; it is a supplement or last-resort option for some patients.
- Treating implantable bioelectronic devices as risk-free because they are 'non-drug'.May underweight the surgical risks of implantation (including possible vocal cord effects), the costs of permanent electrode placement, and the long-term unknowns of device performance over years.
What to expect over time
- Months 1 to 3Initial assessment with rheumatologist. Review prior treatment response, baseline disease activity scores, and whether you meet eligibility criteria for any current vagus nerve stimulation trials.
- Months 3 to 6If enrolled or proceeding with device implantation, surgical placement is followed by titration and gradual symptom tracking. Expect ongoing rheumatology follow-up alongside device monitoring.
- 12+ monthsLonger-term efficacy and safety data are still accumulating. Plan for follow-up that tracks disease activity, device function, and any new alternatives that emerge over time.